Mustang Bio, Inc.
MBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680048
No open-market purchases or sales by Mustang Bio, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $378.3K in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Mustang Bio, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +1 vs. Q1 2025
- Shares held
- 74.3K
- −39.6K (−34.8%) vs. Q1 2025
- Total value
- $70.9K
- −$71.4K (−50.2%) vs. Q1 2025
- New holders
- 3
- 4 more added
- Sold out
- 2
- 3 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $378.3K |
| Q1 2026 | 22 | $369.8K |
| Q4 2025 | 25 | $541.9K |
| Q3 2025 | 20 | $426.5K |
| Q2 2025 | 17 | $70.9K |
| Q1 2025 | 16 | $142.3K |
| Q4 2024 | 30 | $826.5K |
| Q3 2024 | 25 | $207.2K |
| Q2 2024 | 29 | $372.6K |
| Q1 2024 | 30 | $773.1K |
| Q4 2023 | 28 | $1.40M |
| Q3 2023 | 27 | $1.22M |
| Q2 2023 | 28 | $3.94M |
| Q1 2023 | 52 | $3.62M |
| Q4 2022 | 66 | $4.71M |
| Q3 2022 | 70 | $6.80M |
| Q2 2022 | 77 | $10.3M |
| Q1 2022 | 85 | $25.3M |
| Q4 2021 | 88 | $46.4M |
| Q3 2021 | 83 | $71.8M |
| Q2 2021 | 98 | $85.9M |
| Q1 2021 | 99 | $80.6M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Mustang Bio, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 28,069 | $26.8K | 0.00% | +28,069 | New |
| UBS Group AG | 22,585 | $21.6K | 0.00% | −24,955−52.5% | Reduced |
| Geode Capital Management, LLC | 16,082 | $15.4K | 0.00% | +315+2.0% | Added |
| Tower Research Capital LLC (TRC) | 3,978 | $3.80K | 0.00% | +2,078+109.4% | Added |
| BlackRock, Inc. | 1,665 | $1.59K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,006 | $961 | 0.00% | +1,006 | New |
| SBI Securities Co., Ltd. | 502 | $479 | 0.00% | +100+24.9% | Added |
| Morgan Stanley | 237 | $226 | 0.00% | −61−20.5% | Reduced |
| Harbour Investments, Inc. | 76 | $73 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 33 | $32 | 0.00% | +17+106.3% | Added |
| Raymond James Financial Inc | 16 | $16 | 0.00% | +16 | New |
| BNP Paribas Arbitrage, SA | 6 | $6 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2 | $2 | 0.00% | −66−97.1% | Reduced |
| Danske Bank A/S | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Anson Funds Management LP | 0 | $0 | 0.00% | −45,716−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −400−100.0% | Sold out |